Comparison of clinico-pathological characteristics and survival of recurrent ovarian cancer patients on seven different chemo-protocols

Publicado en línea: 07 dic 2018

Páginas: 87 - 97

Aceptado: 16 jul 2018

DOI: https://doi.org/10.2478/acph-2019-0002

Palabras clave

ovarian cancer, carboplatin plus paclitaxel, topotecan, bevacizumab, docetaxel

© 2019 Saima Sattar et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.